Neurology Articles

Neurology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Vandenbark AA et al. – This striking enhancement of two prominent immunoregulatory pathways lends support to the idea that beneficial effects of IFN–beta–1a in MS include control of pernicious autoimmunity.

Related Articles

APOE-epsilon4 is not associated with cognitive impairment in relapsing-remitting multiple sclerosis
Multiple Sclerosis, 11/19/09    Relevance Score: 69%

Early Psychiatric Manifestation in a Patient with Primary Progressive Multiple Sclerosis
Archives of Iranian Medicine, 11/12/09    Relevance Score: 69%

Cochlear implantation in a profoundly deaf patient who also suffers from multiple sclerosis - a case study
Cochlear Implants International, 10/27/09    Relevance Score: 69%

A single-centre, randomized, double-blind, placebo-controlled study of interferon beta-1b on primary progressive and transitional multiple sclerosis
Multiple Sclerosis, 10/01/09    Relevance Score: 69%

Early Drug Treatment May Cut Multiple Sclerosis Risk
MedLinePlus, 10/08/09    Relevance Score: 68%

Today in Demyelinating Disorders...keeping you current

Rasch Validation of the Falls Prevention Strategies Survey
Archives of Physical Medicine and Rehabilitation, 12/18/09

An uncommon illness with a rare presentation: neurosurgical management of ADEM with tumefactive demyelination in children
Child's Nervous System, 12/18/09

Modafinil for multiple sclerosis fatigue: Does it work
Clinical Neurology and Neurosurgery, 12/18/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address